Your browser doesn't support javascript.
loading
Safety and pharmacokinetics-pharmacodynamics of a shorter tuberculosis treatment with high-dose pyrazinamide and rifampicin: a study protocol of a phase II clinical trial (HighShort-RP).
Ekqvist, David; Bornefall, Anna; Augustinsson, Daniel; Sönnerbrandt, Martina; Nordvall, Michaela Jonsson; Fredrikson, Mats; Carlsson, Björn; Sandstedt, Mårten; Simonsson, Ulrika S H; Alffenaar, Jan-Willem C; Paues, Jakob; Niward, Katarina.
Afiliação
  • Ekqvist D; Department of Infectious Diseases, Region Östergötland, Linköping University, Linköping, Sweden.
  • Bornefall A; Department of Infectious Diseases, Region Östergötland, Linköping, Sweden.
  • Augustinsson D; Department of Infectious Diseases, Region Östergötland, Norrköping, Sweden.
  • Sönnerbrandt M; Department of Infectious Diseases, Region Östergötland, Linköping, Sweden.
  • Nordvall MJ; Department of Clinical Microbiology, and Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
  • Fredrikson M; Forum Östergötland, Linköping University, Linköping, Sweden.
  • Carlsson B; Department of Clinical Pharmacology, and Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
  • Sandstedt M; Department of Radiology in Linköping, and Department of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden.
  • Simonsson USH; Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden.
  • Alffenaar JC; School of Pharmacy, The University of Sydney Faculty of Medicine and Health, Sydney, New South Wales, Australia.
  • Paues J; Sydney Institute for Infectious Diseases, The University of Sydney, Sydney, New South Wales, Australia.
  • Niward K; Westmead Hospital, Sydney, New South Wales, Australia.
BMJ Open ; 12(3): e054788, 2022 03 10.
Article em En | MEDLINE | ID: mdl-35273049

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirazinamida / Tuberculose Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirazinamida / Tuberculose Idioma: En Ano de publicação: 2022 Tipo de documento: Article